You have 4 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Graft-Versus-Tumor/Melanoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Therapeutic Drug Monitoring and Serum TNFa Levels in Pediatric

Completed
  • Acute Graft-versus-host Disease
    • Trieste, Italy
      IRCCS Burlo Garofolo
    Apr 11, 2023

    Uveal Melanoma Trial in Germany (Autologous Dendritic Cells loaded with autologous Tumor RNA)

    Active, not recruiting
    • Uveal Melanoma
    • Autologous Dendritic Cells loaded with autologous Tumor RNA
    • Erlangen, Bayern, Germany
    • +7 more
    Nov 29, 2022

    Advanced Melanoma Trial in Pittsburgh (Pembrolizumab Injection [Keytruda], Metformin)

    Recruiting
    • Advanced Melanoma
    • Pittsburgh, Pennsylvania
      Univ of Pittsburgh Medical Center Hillman Cancer Center
    Jan 24, 2022

    Acute GVHD Trial in Zhengzhou (Jaktinib Hydrochloride Tablets)

    Not yet recruiting
    • Acute Graft-Versus-Host Disease
    • Jaktinib Hydrochloride Tablets
    • Zhengzhou, Henan, China
      Henan Tumor Hospital
    Nov 29, 2021

    Pediatric HSCT Recipients With aGVHD: Prospective Observational

    Recruiting
    • Graft Versus Host Disease, Acute
    • Hematopoietic Stem Cell Transplantation
      • Trieste, Italy
        IRCCS Burlo Garofolo
      Apr 30, 2022

      Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem

      Active, not recruiting
      • Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies
      • Recipients
      • Donors
      • Paris, France
        Hopital Necker
      Nov 19, 2021

      Hematological Tumors, Recurrence Trial in Shanghai (Peg interferon alfa-2b)

      Recruiting
      • Hematological Neoplasms
      • Recurrence
      • Peg interferon alfa-2b
      • Shanghai, Shanghai, China
        Shanghai Jiao Tong University Affilated First People's Hospital
      Oct 10, 2021

      Hematological Malignancies Trial in Nijmegen (MiHA-loaded PD-L-silenced DC Vaccination)

      Completed
      • Hematological Malignancies
      • MiHA-loaded PD-L-silenced DC Vaccination
      • Nijmegen, Gelderland, Netherlands
        Trialoffice Haematology-Oncology
      Mar 31, 2021

      Metastatic Melanoma Trial in Germany (molecular tissue analysis)

      Recruiting
      • Metastatic Melanoma
      • molecular tissue analysis
      • Tuebingen, Baden-Württemberg, Germany
      • +13 more
      Feb 28, 2023

      Metastatic Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Portland (GB1211, Pembrolizumab, Placebo)

      Not yet recruiting
      • Metastatic Melanoma
      • Head and Neck Squamous Cell Carcinoma
      • Portland, Oregon
        Providence Portland Medical Center
      Jun 19, 2023

      Leukemia, Myeloid, Acute, MDS, Myelodysplastic Syndrome Acute Myeloid Leukemia Trial in Denver (Nivolumab)

      Withdrawn
      • Leukemia, Myeloid, Acute
      • +2 more
      • Denver, Colorado
        Colorado Blood Cancer Institute
      Apr 20, 2021

      Uveal Melanoma Trial in Ribeirão Preto (Melphalan Injection, Plaque brachytherapy)

      Enrolling by invitation
      • Uveal Melanoma
      • Melphalan Injection
      • Plaque brachytherapy
      • Ribeirão Preto, SP, Brazil
        Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto
      May 29, 2023

      Melanoma Recurrence With Circulating Tumor DNA (ctDNA)

      Active, not recruiting
      • Melanoma
        • Murray, Utah
        • +1 more
        Feb 17, 2023

        Advanced Melanoma Trial in Worldwide (IMC-F106C, Nivolumab, Nivolumab + Relatlimab)

        Not yet recruiting
        • Advanced Melanoma
        • IMC-F106C
        • +2 more
        • La Jolla, California
        • +61 more
        Oct 31, 2023

        Clinical Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage IIIA Cutaneous

        Recruiting
        • Clinical Stage III Cutaneous Melanoma AJCC v8
        • +5 more
        • Jacksonville, Florida
        • +2 more
        Oct 21, 2022

        Leptomeningeal Metastasis, NSCLC Stage IV, Melanoma Stage IV Trial in Geneva, St Gallen, Zurich (intrathecal nivolumab and

        Recruiting
        • Leptomeningeal Metastasis
        • +2 more
        • intrathecal nivolumab and intrathecal ipilimumab
        • Geneva, Switzerland
        • +2 more
        Dec 18, 2022

        Immunotherapy Among BRAF-Positive Melanoma Patients Treated in

        Completed
        • Metastatic Melanoma
        • East Hanover, New Jersey
          Novartis Investigative Site
        Nov 11, 2022

        Acral Lentiginous Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in

        Active, not recruiting
        • Acral Lentiginous Melanoma
        • +3 more
        • Biospecimen Collection
        • +4 more
        • Birmingham, Alabama
        • +822 more
        Jan 28, 2023

        Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Malignant Solid Tumor Trial in

        Active, not recruiting
        • Clinical Stage III Cutaneous Melanoma AJCC v8
        • +4 more
        • Phoenix, Arizona
        • +48 more
        Jan 3, 2023

        AML/MDS Trial in Copenhagen (iDLI)

        Recruiting
        • AML/MDS
        • iDLI
        • Copenhagen, Denmark
          Copenhagen University Hospital, Rigshospitalet
        Jan 13, 2023

        Anal Melanoma, Bladder Melanoma, Cervical Melanoma Trial in United States (Cabozantinib S-malate, Nivolumab, Placebo

        Recruiting
        • Anal Melanoma
        • +18 more
        • Cabozantinib S-malate
        • +5 more
        • Los Angeles, California
        • +53 more
        Jan 31, 2023

        Clinical and Biological Factors Determining Outcomes in Chronic

        Recruiting
        • Chronic Graft vs Host Disease
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Aug 24, 2022

          Acral Lentiginous Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma Trial in United States

          Recruiting
          • Acral Lentiginous Melanoma
          • +6 more
          • Birmingham, Alabama
          • +309 more
          Nov 8, 2021

          Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Los

          Recruiting
          • Anatomic Stage IV Breast Cancer AJCC v8
          • +5 more
          • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
          • +3 more
          • Los Angeles, California
            USC/Norris Comprehensive Cancer Center
          Jan 31, 2023

          Liver Cancer, Tumor Recurrence, Hepatocellular Carcinoma Trial in Bologna (Hypothermic oxygenated Perfusion - HOPE)

          Not yet recruiting
          • Liver Cancer
          • +4 more
          • Hypothermic oxygenated Perfusion - HOPE
          • Bologna, Italy
            IRCCS Azienda Ospedaliero-Universitaria di Bologna
          May 16, 2023